European-wide survey of the EAU Young Academic Urologists

16/01/2015

Androgen deprivation therapy is a cornerstone in the management of prostate cancer. Although it may improve survival in several settings, it is responsible for both short-term and long-term adverse effects leading to a decline in health-related quality of life.

We, the Prostate Cancer Working Group of the EAU Young Academic Urologists, are conducting a European-wide survey on patterns and preferences of management of androgen deprivation therapy-induced adverse effects.

We would like to invite you to complete this 5-minute survey through the following link: https://nl.surveymonkey.com/s/6BHJPTV. All the questions are referring to patients treated with any form of androgen deprivation therapy for at least 6 months.

Many thanks for your precious help!

 

With our best regards,

Members of Prostate Cancer Working Group of the EAU Young Academic Urologists